Skip to main content
Công ty Cổ phần Dược Hậu Giang logo

Công ty Cổ phần Dược Hậu Giang — Investor Relations & Filings

Ticker · DHG ISIN · VN000000DHG0 HSX Manufacturing
Open in API
Filings indexed 141 across all filing types
Latest filing 2026-05-05 Notice of Dividend Amou…
Country VN Viet Nam
Listing HSX DHG

About Công ty Cổ phần Dược Hậu Giang

www.dhgpharma.com.vn

Công ty Cổ phần Dược Hậu Giang (DHG Pharma) is a leading pharmaceutical enterprise with over 50 years of experience. The company specializes in the research, development, manufacturing, and distribution of a diverse portfolio of pharmaceutical products, including both supportive and treatment medications. DHG Pharma emphasizes the application of high technology and international production standards to ensure product quality. Key brands include Telfor, Bocalex, Natto DHA, Hapacol, and Biofermin, serving a broad consumer base. Committed to public health, DHG Pharma actively engages in community health initiatives and strives to provide high-quality, accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
DHG: Thông báo ngày ĐKCC trả cổ tức đợt 1 năm 2025 bằng tiền
Notice of Dividend Amount Classification · 91% confidence The document is a disclosure from the Ho Chi Minh City Stock Exchange notifying shareholders of the ex-dividend date, record date, dividend ratio (50% par or 5,000 VND per share), and payment date for the first cash dividend of 2025 for DHG. This exactly matches the definition of a Notice of Dividend Amount (DIV).
2026-05-05 Vietnamese
DHG: Thông báo thay đổi nhân sự
Board/Management Information Classification · 92% confidence The document is a formal notification of a personnel change—specifically the appointment and title adjustment of a senior executive (Deputy General Director in charge of Finance and Supply Chain) by the Board of Directors, filed with the State Securities Commission and the Ho Chi Minh Stock Exchange. It clearly falls under announcements of changes in senior management, which corresponds to the Board/Management Information category.
2026-04-29 Vietnamese
DHG: Thông báo về ngày đăng ký cuối cùng, sửa đổi Điều lệ, Quy chế nội bộ, Quy chế hoạt động HĐQT
Regulatory Filings Classification · 87% confidence The document is an “Extraordinary Information Disclosure” submitted to the State Securities Commission and Ho Chi Minh Stock Exchange. It contains multiple statutory announcements: record date and payment date for dividends, amendments to the company charter, and internal regulations on governance and board operations. It is not a standalone dividend notice (DIV) or governance report (CGR) but a general regulatory announcement combining several compliance items. Therefore it best fits the fallback category Regulatory Filings (RNS).
2026-04-22 Vietnamese
DHG: Thông báo thay đổi nhân sự - Miễn nhiệm và bổ nhiệm thành viên HĐQT nhiệm kỳ V (2024-2028)
Board/Management Information Classification · 85% confidence The document is headed “THÔNG BÁO THAY ĐỔI NHÂN SỰ” (Notice of Personnel Change) and is filed with the State Securities Commission and Ho Chi Minh Stock Exchange to announce the appointment of a new board member and the dismissal/resignation of another. Although it also includes the full AGM resolution text, the primary purpose is to disclose changes in the company’s board of directors. This falls squarely under Board/Management Information.
2026-04-22 Vietnamese
DHG: Biên bản họp và Nghị quyết ĐHĐCĐ thường niên năm 2025
AGM Information Classification · 87% confidence The document is the formal Resolution (Nghị quyết) and Minutes (Biên bản) of the 2025 Annual General Meeting of Shareholders of DHG Pharmaceutical JSC held on 21 April 2026. It details the agenda items approved by shareholder vote, election results, financial and dividend approvals, and amendments to the charter, all of which are materials produced and shared as part of the AGM. This fits squarely under AGM Information, rather than a standalone financial report, earnings release, or voting-only declaration.
2026-04-22 Tagalog
DHG: Giải trình KQKD quý 1/2026 so với cùng kỳ năm trước
Earnings Release Classification · 85% confidence The document is an official disclosure to the State Securities Commission and Ho Chi Minh Stock Exchange providing key financial highlights for Q1/2026 (net sales, PBT, PAT and brief commentary). It is not a full interim report with complete financial statements but a summary announcement of quarterly results. This matches the definition of an Earnings Release (ER). Q1 2026
2026-04-20 Vietnamese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.